Metabolic syndrome
Endocrine · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A cluster of cardiometabolic risk factors — central obesity, raised blood pressure and glucose, high triglycerides and low HDL — that together markedly raise the risk of type 2 diabetes and cardiovascular disease. Management treats the whole cluster with weight loss and targeted therapy. First action: measure waist, BP, fasting glucose/HbA1c and a lipid profile, and address them together.
Red flags
- Usually managed in primary care
- Refer for specialist weight-management/bariatric assessment, resistant hypertension, or significant MASLD/other complications
- The emphasis is proactive risk reduction, not admission
Assessment
Investigations
- Waist circumference and BMI, blood pressure, fasting glucose/HbA1c, fasting lipid profile (triglycerides, HDL, LDL)
- Assess cardiovascular risk (QRISK/PREVENT); screen for MASLD (LFTs, FIB-4), OSA and, where relevant, PCOS
- Exclude secondary causes of individual components
Management
- Lifestyle is the foundation and treats every component: structured weight loss (≥5–10%), a healthy diet, regular activity, reduced alcohol and smoking cessation
- Then treat the individual risk factors to target — hypertension, dyslipidaemia (statin by risk), and glucose/prediabetes (metformin and lifestyle;
- GLP-1/SGLT2i where diabetes/obesity co- exist)
- Treat associated MASLD and OSA
- Consider obesity pharmacotherapy or bariatric surgery for eligible patients
Disposition
Usually managed in primary care.
Complications & pitfalls
- Progression to type 2 diabetes, atherosclerotic cardiovascular disease (MI, stroke), MASLD/MASH and cirrhosis, chronic kidney disease, and obstructive sleep apnoea
Exam pearls
- Metabolic syndrome is a call to treat the whole cardiometabolic cluster, not one number — weight loss improves every component at once, and catching it is the chance to prevent both diabetes and cardiovascular disease.
- Monitoring & follow-up: Periodic weight/waist, BP, HbA1c and lipids; reassess cardiovascular risk and reinforce lifestyle at each review. Monitor and treat emerging diabetes, MASLD and other complications.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.